The University of Chicago Header Logo

Connection

John Moroney to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications John Moroney has written about Maximum Tolerated Dose.
John Moroney
Connection Strength
0.092
Maximum Tolerated Dose
  1. Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity. Clin Cancer Res. 2012 Oct 15; 18(20):5796-805.
    View in: PubMed
    Score: 0.092
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.